The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Serum concentrations of oncometabolite, 2-hydroxyglutarate (2HG), as biomarkers for isocitrate dehydrogenase (IDH1/2) mutations in cholangiocarcinoma (ICCA).
 
Cha Len Lee
No Relationships to Disclose
 
Warren P. Mason
Honoraria - Bayer
Expert Testimony - Medcan
 
Grainne M. O'Kane
Honoraria - AstraZeneca; Eisai; Roche
Consulting or Advisory Role - AstraZeneca Canada; Eisai; Incyte; Roche
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Robert C. Grant
No Relationships to Disclose
 
Jennifer J. Knox
Honoraria - AstraZeneca; Roche Canada
Consulting or Advisory Role - AstraZeneca/MedImmune; Incyte; Ipsen; Lilly; Merck
Research Funding - AstraZeneca; Ipsen; Merck
Expert Testimony - AstraZeneca
 
Candice Cruz
No Relationships to Disclose
 
Wenjiang Zhang
No Relationships to Disclose
 
Gelareh Zadeh
No Relationships to Disclose
 
Eric Xueyu Chen
Honoraria - AstraZeneca Canada; Bayer; Eisai; Ipsen; Roche Canada
Research Funding - 1Globe Health Institute; AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Sharp & Dohme; Mirati Therapeutics; Novartis; Nubiyota; Repare Therapeutics; Roche Canada